Kyle is responsible for managing Actuated’s Neural Devices R&D programs as well as commercial activities of the NeuralGlider Inserter, which uses ultrasonic micro-vibration to reduce forces and resultant dimpling during neural implant insertions. Currently, he manages preclinical research studies with partnering investigators at Carnegie Mellon University, the University of Pittsburgh, the University of North Carolina, Penn State University, and others. Actuated’s active neuroscience research programs also include the development of surgical tools for peripheral nerve electrode and deep brain stimulation electrode implantation, as well as therapeutic ultrasound technologies for neural applications. Kyle earned his B.S. in Biochemistry and Molecular Biology from Penn State University as well as his Ph.D. in Molecular Cellular and Integrative Biosciences.

John is responsible for managing Actuated’s National Institutes of Health (NIH) Blueprint MedTech (BPMT) initiative contract. He is point of contact with BPMT awardees to ensure that Actuated can assist the them with biocompatibility studies, in vivo preclinical testing with adherence to good laboratory practice (GLP) guidelines, and sterilization and shelf-life testing which are crucial for advancing medical device development. As Actuated scientific outreach leader, he is responsible for continual end-user discovery of our Actuated Neuroscience portfolio. As senior neuroscientist, he is leveraging Actuated’s expertise in ultrasound and surgical tools to develop research programs to treat closed head injuries and cell culture incubators. John earned his B.S. in Psychology from Louisiana State University, a Ph.D. in Behavioral Neuroscience from the Ohio State University and was recently Research Assistant Professor of Neurobiology and Anatomy at the McGovern Medical School of Houston.

Kevin is responsible for development and optimization of new device concepts as well as continued advancement and evolution of Actuated’s current technologies. He focuses on performance metrics and evaluation throughout the design process. In addition, he mentors company engineers in finite element analysis and predictive device design. Kevin has expertise in electroactive/piezoelectric materials, acoustics and photoacoustics, electronics, and active device design principles. Kevin earned his B.S. in Biomedical Engineering from Johns Hopkins University and his M.S. and Ph.D. in Bioengineering from Penn State University.

Olga is responsible for determining how Actuated’s products will be received by payers and what reimbursement strategy we shall pursue via interactions with Centers for Medicare & Medicaid Services (CMS). Additionally, as clinical Site Monitor, she assists Actuated Medical’s Director Quality Assurance & Regulatory Affairs to execute and oversee ongoing clinical studies, focusing on IRB application preparation and serving as the coordinator between Actuated Medical and clinicians. Olga earned her B.S. in Animal Science from the University of Florida and both her M.S. and Ph.D. in Physiology from the Pennsylvania State University.

Jenna graduated from the Pennsylvania State University in 2013 with a B.S. in Bioengineering. She has expertise in solid model design and device protocol and test development. She has worked on neuroscience animal studies with a wide variety of neural implants. She serves as the technical support point-of-contact for inquiries regarding the NeuralGlider Inserter.

Kiara is responsible for curating and disseminating external materials and strategically managing the media presence for NeuralGlider, highlighting the benefits of our solutions for preclinical researchers from an engineering perspective. Additionally, she fulfills a role as an engineer within the neural devices team, driving the advancement of innovative solutions designed for Neuroscience experts. Kiara earned her B.S. in Biomedical Engineering from Duquesne University.